Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.125 CAD | -3.85% | -7.41% | +56.25% |
Apr. 18 | Transcript : Kane Biotech Inc. - Special Call | |
Apr. 15 | Kane Biotech Up 12% After Reporting Closing of STEM Animal Health Sale | MT |
Sales 2022 | 2.67M 1.95M | Sales 2023 | 149K 109K | Capitalization | 10.55M 7.71M |
---|---|---|---|---|---|
Net income 2022 | -3M -2.19M | Net income 2023 | -5M -3.66M | EV / Sales 2022 | 6.37 x |
Net Debt 2022 | 5.76M 4.21M | Net Debt 2023 | 8.51M 6.22M | EV / Sales 2023 | 128 x |
P/E ratio 2022 |
-2.79
x | P/E ratio 2023 |
-2.02
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.07% |
Latest transcript on Kane Biotech Inc.
1 day | -3.85% | ||
1 week | -7.41% | ||
Current month | +25.00% | ||
1 month | +19.05% | ||
3 months | +56.25% | ||
6 months | +66.67% | ||
Current year | +56.25% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Edwards
CEO | Chief Executive Officer | - | 16-06-01 |
Ray Dupuis
DFI | Director of Finance/CFO | - | 17-09-04 |
Compliance Officer | - | 19-08-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
R. Renaud
BRD | Director/Board Member | - | 10-09-14 |
Chairman | 59 | Feb. 19 | |
Georges Morin
BRD | Director/Board Member | - | 20-05-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.125 | -3.85% | 31,500 |
24-04-25 | 0.13 | +4.00% | 12,000 |
24-04-24 | 0.125 | -3.85% | 150,900 |
24-04-23 | 0.13 | -7.14% | 27,500 |
24-04-22 | 0.14 | +3.70% | 5,000 |
Delayed Quote Toronto S.E., April 26, 2024 at 03:44 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+56.25% | 12.51M | |
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |
- Stock Market
- Equities
- KNE Stock